The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits.
Read More
Welcome to the inaugural issue of CHPR—our fourth CME newsletter. Unlike our other newsletters, which are focused on outpatient practice, the focus of CHPR is on hospital psychiatry, including inpatient units, emergency rooms, and consult liaison work.
Read More
Imagine a drug that resolves depression within hours in people at imminent risk of suicide. Esketamine may be such a drug — but is it a miracle cure? Here we look at the data and discuss the pros and cons of this new treatment.
Read More
Dr. Laura Tormoehlen discusses the management of neuroleptic malignant syndrome and serotonin syndrome and summarizes how to distinguish between these acute conditions.
Read More
Why would anyone deliberately swallow a nondigestible object? What items require emergent removal, vs simple monitoring? And how can you help patients who repeatedly swallow foreign bodies?
Read More
Dr. T. Scott Stroup, Professor of Psychiatry at Columbia University, reveals surprising findings from his research on the use of adjunctive medications for schizophrenia.
Read More
How high should we go when dosing antipsychotics in schizophrenia? A recent meta-analysis of 68 studies examined dose-response relationships in randomized controlled trials of antipsychotic medications for schizophrenia and schizoaffective disorder.
Read More
We’re pleased to introduce Victoria Hendrick, MD, as CHPR’s editor-in-chief. Dr. Hendrick is a clinical professor at the David Geffen School of Medicine at UCLA and the director of inpatient psychiatry at Olive View UCLA Medical Center, where she carries a caseload of patients and teaches and supervises medical students and psychiatry residents.
Read More
Dr. Hendrick is a clinical professor at the David Geffen School of Medicine at UCLA and is the director of inpatient psychiatry at Olive View—UCLA Medical Center, where she carries a caseload of patients and provides teaching and supervision for medical students and psychiatry residents. After completing medical school and psychiatric residency at UCLA, she spent several years working as a principal investigator and co-investigator on N.I.M.H. funded research studies. She has authored or co-authored over 75 research papers, editorials, books and other publications. She has a long-standing interest in the needs of severely mentally ill patients from underserved populations and has worked in community mental health settings her entire career.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
